Corcept (CORT) Class Action Alleges Misstatements on FDA Data Concerns - Hagens Berman

Provided By PR Newswire – Last update:

Quotes Stocks Mentioned

Article Mentions:

CORT Investors with Losses Encouraged to Contact Firm

SAN FRANCISCO, April 7, 2026 /PRNewswire/ -- National shareholder rights law firm Hagens Berman reminds investors in Corcept Therapeutics Incorporated (NASDAQ: CORT) that the deadline to move for Lead Plaintiff in the pending securities class action is April 21, 2026.

Read more at prnewswire.com